Chemical inhibitors of 2810485I05Rik include a range of compounds that target various signaling pathways and cellular processes. Staurosporine acts as a potent protein kinase inhibitor, disrupting kinase-dependent signaling that 2810485I05Rik relies on for its activity. By inhibiting these kinases, the precise signaling cascades that facilitate the function of 2810485I05Rik are interrupted, leading to its functional inhibition. Similarly, rapamycin inhibits the mTOR pathway, which is a central cell growth and survival pathway, and this inhibition can limit the downstream effects that may involve 2810485I05Rik's function. Wortmannin and LY294002 are also instrumental in modulating 2810485I05Rik's activity by inhibiting phosphoinositide 3-kinases (PI3K), which are pivotal in cell survival and proliferation signals that 2810485I05Rik may be part of.
In tandem, U0126 and PD98059 specifically inhibit MEK, an upstream kinase in the MAPK/ERK pathway, thus potentially reducing the activity of 2810485I05Rik by limiting the phosphorylation events that lead to its activation. SB203580 targets p38 MAP kinase, impeding the kinase's role in stress response and inflammatory processes that can influence 2810485I05Rik. Similarly, SP600125 inhibits JNK, which plays a role in stress-activated pathways, where 2810485I05Rik may be implicated. ZM-447439 disrupts cell cycle regulation by inhibiting Aurora kinases, which could alter the cellular environment and the context in which 2810485I05Rik operates. PP2 selectively inhibits Src family kinases, which are involved in numerous signaling pathways that could intersect with 2810485I05Rik's function. Bortezomib, by inhibiting the proteasome, potentially leads to an accumulation of regulatory proteins that can impede the function of 2810485I05Rik. Lastly, thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA), which can create conditions that are unfavorable for 2810485I05Rik's activity due to the importance of calcium signaling in numerous cellular functions. Each of these chemicals inhibits a specific aspect of the cellular machinery that is crucial for the normal function of 2810485I05Rik, thereby effectively reducing its activity within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits multiple protein kinases which could be crucial for 2810485I05Rik signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR which may be necessary for 2810485I05Rik downstream signaling and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K which is likely involved in 2810485I05Rik associated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting 2810485I05Rik's function due to its role in related signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, which is upstream in MAPK/ERK pathway, potentially influencing 2810485I05Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, potentially reducing MAPK/ERK pathway activity involving 2810485I05Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, likely involved in stress responses affecting 2810485I05Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could disrupt stress-activated pathways including 2810485I05Rik. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Inhibits Aurora kinases, potentially disrupting cell cycle regulation involving 2810485I05Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, which may alter signaling pathways of 2810485I05Rik. | ||||||